

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.34260334 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.34260334 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.97706482 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.83701741 |
| 5 | detection of molecule of bacterial origin (GO:0032490) | 5.83250172 |
| 6 | positive regulation of interferon-alpha production (GO:0032727) | 5.70792675 |
| 7 | cellular response to type I interferon (GO:0071357) | 5.59443794 |
| 8 | type I interferon signaling pathway (GO:0060337) | 5.59443794 |
| 9 | response to type I interferon (GO:0034340) | 5.56814961 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 5.54646593 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 5.54646593 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.54646593 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.54646593 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.54646593 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 5.54646593 |
| 16 | detection of other organism (GO:0098543) | 5.39634151 |
| 17 | regulation of interferon-alpha production (GO:0032647) | 5.38495395 |
| 18 | cellular response to interferon-alpha (GO:0035457) | 5.22709510 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.18745902 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 5.15743961 |
| 21 | detection of external biotic stimulus (GO:0098581) | 5.15093003 |
| 22 | response to interferon-alpha (GO:0035455) | 5.00561651 |
| 23 | detection of bacterium (GO:0016045) | 4.88733218 |
| 24 | cellular extravasation (GO:0045123) | 4.71265243 |
| 25 | negative regulation of viral genome replication (GO:0045071) | 4.69666872 |
| 26 | response to peptidoglycan (GO:0032494) | 4.66319148 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 4.63180772 |
| 28 | cellular response to exogenous dsRNA (GO:0071360) | 4.55147662 |
| 29 | detection of biotic stimulus (GO:0009595) | 4.49619530 |
| 30 | natural killer cell mediated immunity (GO:0002228) | 4.44377957 |
| 31 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.44377957 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 4.42904043 |
| 33 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.39242691 |
| 34 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.36416127 |
| 35 | leukocyte aggregation (GO:0070486) | 4.35272178 |
| 36 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.32034002 |
| 37 | neutrophil mediated immunity (GO:0002446) | 4.29255119 |
| 38 | regulation of gamma-delta T cell activation (GO:0046643) | 4.27509625 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.26390750 |
| 40 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.25399280 |
| 41 | positive regulation of type 2 immune response (GO:0002830) | 4.21558545 |
| 42 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.20290193 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 4.18896211 |
| 44 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.16143832 |
| 45 | response to host immune response (GO:0052572) | 4.16143832 |
| 46 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.14025398 |
| 47 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.13988600 |
| 48 | response to interleukin-15 (GO:0070672) | 4.13834004 |
| 49 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.12606857 |
| 50 | cellular response to interferon-beta (GO:0035458) | 4.06509275 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.04119695 |
| 52 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.02770241 |
| 53 | respiratory burst (GO:0045730) | 4.02490015 |
| 54 | positive regulation of interferon-beta production (GO:0032728) | 4.02216468 |
| 55 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.01648097 |
| 56 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.99746556 |
| 57 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.99746556 |
| 58 | T-helper 1 type immune response (GO:0042088) | 3.98372107 |
| 59 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.94945024 |
| 60 | granulocyte activation (GO:0036230) | 3.94204410 |
| 61 | regulation of RIG-I signaling pathway (GO:0039535) | 3.91935427 |
| 62 | cellular response to virus (GO:0098586) | 3.87518140 |
| 63 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.84269574 |
| 64 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.84252924 |
| 65 | cellular response to interleukin-15 (GO:0071350) | 3.82676003 |
| 66 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.82330604 |
| 67 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.75856784 |
| 68 | neutrophil activation (GO:0042119) | 3.75549545 |
| 69 | negative regulation of T cell mediated immunity (GO:0002710) | 3.73486968 |
| 70 | response to interferon-beta (GO:0035456) | 3.70608917 |
| 71 | myeloid leukocyte mediated immunity (GO:0002444) | 3.70540165 |
| 72 | regulation of mononuclear cell migration (GO:0071675) | 3.67229935 |
| 73 | regulation of mast cell degranulation (GO:0043304) | 3.67199134 |
| 74 | positive regulation of mast cell activation (GO:0033005) | 3.66508576 |
| 75 | lymphocyte chemotaxis (GO:0048247) | 3.66229440 |
| 76 | response to host (GO:0075136) | 3.66179098 |
| 77 | response to host defenses (GO:0052200) | 3.66179098 |
| 78 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.66179098 |
| 79 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.65481397 |
| 80 | reactive oxygen species biosynthetic process (GO:1903409) | 3.64524976 |
| 81 | defense response to protozoan (GO:0042832) | 3.60472089 |
| 82 | positive regulation of antigen processing and presentation (GO:0002579) | 3.60300251 |
| 83 | regulation of activation of Janus kinase activity (GO:0010533) | 3.58413769 |
| 84 | superoxide anion generation (GO:0042554) | 3.57887868 |
| 85 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.57583081 |
| 86 | eosinophil chemotaxis (GO:0048245) | 3.56157036 |
| 87 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.54563052 |
| 88 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.52668731 |
| 89 | positive regulation of interleukin-12 production (GO:0032735) | 3.51972384 |
| 90 | positive regulation of heat generation (GO:0031652) | 3.51892821 |
| 91 | T cell migration (GO:0072678) | 3.50780985 |
| 92 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.50361339 |
| 93 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.50346042 |
| 94 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.49681106 |
| 95 | microglial cell activation (GO:0001774) | 3.49046001 |
| 96 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.47638288 |
| 97 | B cell mediated immunity (GO:0019724) | 3.46776686 |
| 98 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.44101635 |
| 99 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.43417884 |
| 100 | regulation of chemokine biosynthetic process (GO:0045073) | 3.42699844 |
| 101 | regulation of fever generation (GO:0031620) | 3.40467059 |
| 102 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.39854822 |
| 103 | positive regulation of T cell cytokine production (GO:0002726) | 3.36357337 |
| 104 | regulation of mast cell activation (GO:0033003) | 3.32348775 |
| 105 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.32335315 |
| 106 | positive regulation of interleukin-17 production (GO:0032740) | 3.31149058 |
| 107 | defense response to virus (GO:0051607) | 3.30894752 |
| 108 | cellular response to interferon-gamma (GO:0071346) | 3.30578891 |
| 109 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.30472026 |
| 110 | monocyte chemotaxis (GO:0002548) | 3.29280715 |
| 111 | myeloid cell activation involved in immune response (GO:0002275) | 3.27681990 |
| 112 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.27355183 |
| 113 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.26388676 |
| 114 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.25011870 |
| 115 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.24944059 |
| 116 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.24692713 |
| 117 | dendritic cell migration (GO:0036336) | 3.21389778 |
| 118 | regulation of antigen processing and presentation (GO:0002577) | 3.20938812 |
| 119 | regulation of leukocyte degranulation (GO:0043300) | 3.20896200 |
| 120 | leukocyte mediated cytotoxicity (GO:0001909) | 3.19935840 |
| 121 | positive regulation of mast cell degranulation (GO:0043306) | 3.19832074 |
| 122 | regulation of B cell differentiation (GO:0045577) | 3.19318887 |
| 123 | leukocyte degranulation (GO:0043299) | 3.18621881 |
| 124 | * B cell receptor signaling pathway (GO:0050853) | 3.17472991 |
| 125 | myeloid dendritic cell differentiation (GO:0043011) | 3.16792061 |
| 126 | eosinophil migration (GO:0072677) | 3.16656098 |
| 127 | regulation of tolerance induction (GO:0002643) | 3.16608167 |
| 128 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.15545642 |
| 129 | response to muramyl dipeptide (GO:0032495) | 3.15311726 |
| 130 | positive regulation of response to biotic stimulus (GO:0002833) | 3.09125623 |
| 131 | negative thymic T cell selection (GO:0045060) | 3.07362975 |
| 132 | dendritic cell chemotaxis (GO:0002407) | 3.07045093 |
| 133 | negative regulation of interleukin-17 production (GO:0032700) | 3.05256473 |
| 134 | response to protozoan (GO:0001562) | 3.05249812 |
| 135 | macrophage activation (GO:0042116) | 3.04087625 |
| 136 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.04087457 |
| 137 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.04087457 |
| 138 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.02993446 |
| 139 | myeloid leukocyte activation (GO:0002274) | 3.02705246 |
| 140 | response to interferon-gamma (GO:0034341) | 3.02700680 |
| 141 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.02416470 |
| 142 | negative T cell selection (GO:0043383) | 3.02127531 |
| 143 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.00960316 |
| 144 | negative regulation of type 2 immune response (GO:0002829) | 3.00819978 |
| 145 | regulation of interleukin-17 production (GO:0032660) | 3.00373224 |
| 146 | positive regulation of B cell differentiation (GO:0045579) | 3.00351696 |
| 147 | regulation of T cell tolerance induction (GO:0002664) | 3.00187252 |
| 148 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.96450873 |
| 149 | positive regulation of lymphocyte migration (GO:2000403) | 2.96152583 |
| 150 | cellular response to zinc ion (GO:0071294) | 2.95711651 |
| 151 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.95539917 |
| 152 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.95426318 |
| 153 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.94689268 |
| 154 | positive thymic T cell selection (GO:0045059) | 2.93662877 |
| 155 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.92758643 |
| 156 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.92650161 |
| 157 | negative regulation of B cell mediated immunity (GO:0002713) | 2.91017309 |
| 158 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.91017309 |
| 159 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.89330246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.61358466 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.62383394 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.49958732 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.38280122 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.16917375 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.47472047 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.93854362 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.80078687 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.61455338 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.31994468 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.28521931 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.92209246 |
| 13 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.79767849 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.62763152 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.61985423 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.60133845 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.47252343 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.46126185 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.23798292 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.14909038 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.00122847 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.98341158 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88923103 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.70356810 |
| 25 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69427746 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66683807 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66196302 |
| 28 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.62388276 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.61552983 |
| 30 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.60854261 |
| 31 | MYC_22102868_ChIP-Seq_BL_Human | 1.56640435 |
| 32 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54979825 |
| 33 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.53609073 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.52633592 |
| 35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51717923 |
| 36 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51227547 |
| 37 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50136817 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49491850 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.49249118 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48260015 |
| 41 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44557692 |
| 42 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.43673272 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39539360 |
| 44 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.34487892 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33994897 |
| 46 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.32830875 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.30287376 |
| 48 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26924641 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26735799 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24440009 |
| 51 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24393253 |
| 52 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23443594 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.23397615 |
| 54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.20874022 |
| 55 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.20403836 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20302923 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19981185 |
| 58 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19497222 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19354581 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.19212562 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17723543 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17406181 |
| 63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16575742 |
| 64 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15162590 |
| 65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14580092 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14014141 |
| 67 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13711239 |
| 68 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12318504 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04898242 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04897430 |
| 71 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03672737 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01496903 |
| 73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01496903 |
| 74 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01323622 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00183853 |
| 76 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.99830323 |
| 77 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98443154 |
| 78 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.97970596 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95089317 |
| 80 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94794487 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94452735 |
| 82 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94346373 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94002763 |
| 84 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93854891 |
| 85 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93336211 |
| 86 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92202112 |
| 87 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.89467591 |
| 88 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85615120 |
| 89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85431544 |
| 90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85379043 |
| 91 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84992947 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84428189 |
| 93 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78550687 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.77552686 |
| 95 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.76968543 |
| 96 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76807720 |
| 97 | CJUN_26792858_Chip-Seq_BT549_Human | 0.76806410 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.76765270 |
| 99 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.74458750 |
| 100 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.72862721 |
| 101 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.72184067 |
| 102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71677787 |
| 103 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71044264 |
| 104 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70478006 |
| 105 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.67172116 |
| 106 | UTX_26944678_Chip-Seq_JUKART_Human | 0.66960265 |
| 107 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.66297342 |
| 108 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.66276382 |
| 109 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.64165856 |
| 110 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.63256973 |
| 111 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.63049257 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.61210508 |
| 113 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.60930860 |
| 114 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.60915523 |
| 115 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.60915523 |
| 116 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.60872789 |
| 117 | MAF_26560356_Chip-Seq_TH2_Human | 0.60852041 |
| 118 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.60217145 |
| 119 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.60004484 |
| 120 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.60002986 |
| 121 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.58892721 |
| 122 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.57473397 |
| 123 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.56797863 |
| 124 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.53046051 |
| 125 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52645560 |
| 126 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.51938537 |
| 127 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.50364179 |
| 128 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.45969177 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.44824902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.05573064 |
| 2 | MP0009785_altered_susceptibility_to | 4.31517281 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.92650603 |
| 4 | MP0003436_decreased_susceptibility_to | 3.87394247 |
| 5 | MP0006082_CNS_inflammation | 3.61396606 |
| 6 | MP0003724_increased_susceptibility_to | 3.57735744 |
| 7 | MP0003303_peritoneal_inflammation | 3.31310955 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.30076321 |
| 9 | MP0005025_abnormal_response_to | 3.20646094 |
| 10 | MP0001790_abnormal_immune_system | 3.11548312 |
| 11 | MP0005387_immune_system_phenotype | 3.11548312 |
| 12 | MP0002419_abnormal_innate_immunity | 3.06465595 |
| 13 | MP0000685_abnormal_immune_system | 2.98010393 |
| 14 | MP0004510_myositis | 2.96691047 |
| 15 | MP0005671_abnormal_response_to | 2.86046132 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.65338230 |
| 17 | MP0002723_abnormal_immune_serum | 2.57182772 |
| 18 | MP0001800_abnormal_humoral_immune | 2.54646017 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.52504438 |
| 20 | MP0001533_abnormal_skeleton_physiology | 2.32419432 |
| 21 | MP0001819_abnormal_immune_cell | 2.19907829 |
| 22 | MP0009764_decreased_sensitivity_to | 2.17108986 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.13402684 |
| 24 | MP0002132_abnormal_respiratory_system | 2.00707028 |
| 25 | MP0003448_altered_tumor_morphology | 1.96176132 |
| 26 | MP0004947_skin_inflammation | 1.93767379 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.90338218 |
| 28 | MP0002006_tumorigenesis | 1.78513461 |
| 29 | MP0004883_abnormal_blood_vessel | 1.77411995 |
| 30 | MP0008469_abnormal_protein_level | 1.76001596 |
| 31 | MP0001853_heart_inflammation | 1.75224863 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.74263306 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.73725459 |
| 34 | MP0004381_abnormal_hair_follicle | 1.71878437 |
| 35 | MP0003075_altered_response_to | 1.71550566 |
| 36 | MP0005451_abnormal_body_composition | 1.69738519 |
| 37 | MP0003866_abnormal_defecation | 1.61931755 |
| 38 | MP0000343_altered_response_to | 1.61895805 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.61499059 |
| 40 | MP0002405_respiratory_system_inflammati | 1.60597563 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.60428715 |
| 42 | MP0009278_abnormal_bone_marrow | 1.59666699 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.59295941 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.54636099 |
| 45 | MP0000716_abnormal_immune_system | 1.51898061 |
| 46 | MP0005310_abnormal_salivary_gland | 1.51113570 |
| 47 | MP0008438_abnormal_cutaneous_collagen | 1.46270873 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.41306830 |
| 49 | MP0000858_altered_metastatic_potential | 1.40224651 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.38701853 |
| 51 | MP0009840_abnormal_foam_cell | 1.38677464 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.36568222 |
| 53 | MP0002398_abnormal_bone_marrow | 1.36012018 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.28334542 |
| 55 | MP0004782_abnormal_surfactant_physiolog | 1.27585443 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.27272999 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.27272999 |
| 58 | MP0005164_abnormal_response_to | 1.25452285 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 1.23940600 |
| 60 | MP0005166_decreased_susceptibility_to | 1.18380075 |
| 61 | MP0005390_skeleton_phenotype | 1.17556701 |
| 62 | MP0002429_abnormal_blood_cell | 1.16955327 |
| 63 | MP0000604_amyloidosis | 1.16371511 |
| 64 | MP0003186_abnormal_redox_activity | 1.15304705 |
| 65 | MP0002254_reproductive_system_inflammat | 1.09378237 |
| 66 | MP0009763_increased_sensitivity_to | 1.08540461 |
| 67 | MP0010307_abnormal_tumor_latency | 1.08024605 |
| 68 | MP0005075_abnormal_melanosome_morpholog | 1.02383930 |
| 69 | MP0005076_abnormal_cell_differentiation | 1.02294777 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.01231941 |
| 71 | MP0000015_abnormal_ear_pigmentation | 0.99273837 |
| 72 | MP0003300_gastrointestinal_ulcer | 0.99194763 |
| 73 | MP0003690_abnormal_glial_cell | 0.97768944 |
| 74 | MP0003045_fibrosis | 0.97304011 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.96967660 |
| 76 | MP0002722_abnormal_immune_system | 0.96000288 |
| 77 | MP0003195_calcinosis | 0.94733971 |
| 78 | MP0000569_abnormal_digit_pigmentation | 0.94370023 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 0.93899365 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.92978948 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 0.91711311 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 0.90886176 |
| 83 | MP0003091_abnormal_cell_migration | 0.89454686 |
| 84 | MP0003787_abnormal_imprinting | 0.84772112 |
| 85 | MP0004858_abnormal_nervous_system | 0.84183942 |
| 86 | MP0003566_abnormal_cell_adhesion | 0.80345510 |
| 87 | MP0001851_eye_inflammation | 0.77678813 |
| 88 | MP0002933_joint_inflammation | 0.76180392 |
| 89 | MP0001663_abnormal_digestive_system | 0.75330826 |
| 90 | MP0004130_abnormal_muscle_cell | 0.75007683 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.74688792 |
| 92 | MP0000249_abnormal_blood_vessel | 0.74661812 |
| 93 | MP0008004_abnormal_stomach_pH | 0.72638492 |
| 94 | MP0003763_abnormal_thymus_physiology | 0.69880306 |
| 95 | MP0001958_emphysema | 0.69321751 |
| 96 | MP0001348_abnormal_lacrimal_gland | 0.68219484 |
| 97 | MP0004484_altered_response_of | 0.68098645 |
| 98 | MP0008874_decreased_physiological_sensi | 0.68066176 |
| 99 | MP0003828_pulmonary_edema | 0.67460267 |
| 100 | MP0005174_abnormal_tail_pigmentation | 0.64184364 |
| 101 | MP0003795_abnormal_bone_structure | 0.63317585 |
| 102 | MP0001881_abnormal_mammary_gland | 0.62294711 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.62259440 |
| 104 | MP0005023_abnormal_wound_healing | 0.61487570 |
| 105 | MP0003806_abnormal_nucleotide_metabolis | 0.61399742 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.60734135 |
| 107 | MP0003183_abnormal_peptide_metabolism | 0.59631482 |
| 108 | MP0010386_abnormal_urinary_bladder | 0.59576607 |
| 109 | MP0002133_abnormal_respiratory_system | 0.59253532 |
| 110 | MP0005388_respiratory_system_phenotype | 0.59253532 |
| 111 | MP0005257_abnormal_intraocular_pressure | 0.58559882 |
| 112 | MP0003252_abnormal_bile_duct | 0.58094487 |
| 113 | MP0005376_homeostasis/metabolism_phenot | 0.57367901 |
| 114 | MP0001986_abnormal_taste_sensitivity | 0.57151497 |
| 115 | MP0005275_abnormal_skin_tensile | 0.56533468 |
| 116 | MP0002928_abnormal_bile_duct | 0.56370730 |
| 117 | MP0002090_abnormal_vision | 0.55964424 |
| 118 | MP0003705_abnormal_hypodermis_morpholog | 0.55916464 |
| 119 | MP0008260_abnormal_autophagy | 0.55729825 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.55482494 |
| 121 | MP0004808_abnormal_hematopoietic_stem | 0.51870054 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.50567179 |
| 123 | MP0000490_abnormal_crypts_of | 0.50351880 |
| 124 | MP0003329_amyloid_beta_deposits | 0.49132364 |
| 125 | MP0005165_increased_susceptibility_to | 0.48464563 |
| 126 | MP0002295_abnormal_pulmonary_circulatio | 0.48377217 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.47811749 |
| 128 | MP0000627_abnormal_mammary_gland | 0.47024793 |
| 129 | MP0005083_abnormal_biliary_tract | 0.46385872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.64251718 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.84688624 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.64694383 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.02729793 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.31115818 |
| 6 | Autoimmune thrombocytopenia (HP:0001973) | 5.30966077 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 4.90083387 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.77828941 |
| 9 | Increased IgM level (HP:0003496) | 4.66989577 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.32977375 |
| 11 | Basal ganglia calcification (HP:0002135) | 4.30722857 |
| 12 | Keratoconjunctivitis sicca (HP:0001097) | 4.30280539 |
| 13 | Recurrent skin infections (HP:0001581) | 4.24267694 |
| 14 | Gingivitis (HP:0000230) | 4.18752608 |
| 15 | Keratoconjunctivitis (HP:0001096) | 3.97594215 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.94346610 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.91090086 |
| 18 | Hypochromic microcytic anemia (HP:0004840) | 3.88360091 |
| 19 | Encephalitis (HP:0002383) | 3.87960214 |
| 20 | Stomatitis (HP:0010280) | 3.86545865 |
| 21 | Vasculitis (HP:0002633) | 3.83873249 |
| 22 | T lymphocytopenia (HP:0005403) | 3.63227913 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.62690943 |
| 24 | Recurrent viral infections (HP:0004429) | 3.60031921 |
| 25 | Interstitial pulmonary disease (HP:0006530) | 3.59812066 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 3.58072320 |
| 27 | Obstructive lung disease (HP:0006536) | 3.57816620 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.57816620 |
| 29 | Tetraparesis (HP:0002273) | 3.55372237 |
| 30 | Myositis (HP:0100614) | 3.52204740 |
| 31 | Prostate neoplasm (HP:0100787) | 3.51643295 |
| 32 | Hypergammaglobulinemia (HP:0010702) | 3.51011715 |
| 33 | Orchitis (HP:0100796) | 3.47798366 |
| 34 | Chronic otitis media (HP:0000389) | 3.47367111 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.44944086 |
| 36 | Chest pain (HP:0100749) | 3.43946822 |
| 37 | Axonal loss (HP:0003447) | 3.39350099 |
| 38 | Thick nail (HP:0001805) | 3.35620468 |
| 39 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.25587747 |
| 40 | Hypochromic anemia (HP:0001931) | 3.23237568 |
| 41 | Cellulitis (HP:0100658) | 3.19792258 |
| 42 | Optic neuritis (HP:0100653) | 3.16511061 |
| 43 | Retrobulbar optic neuritis (HP:0100654) | 3.16511061 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.15746564 |
| 45 | Recurrent cutaneous fungal infections (HP:0011370) | 3.15746564 |
| 46 | Periodontitis (HP:0000704) | 3.14509543 |
| 47 | Prolonged bleeding time (HP:0003010) | 3.08343076 |
| 48 | Porencephaly (HP:0002132) | 3.05651319 |
| 49 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.01828845 |
| 50 | Episodic fever (HP:0001954) | 3.01118222 |
| 51 | Recurrent pneumonia (HP:0006532) | 2.96400995 |
| 52 | Urticaria (HP:0001025) | 2.93887243 |
| 53 | Pustule (HP:0200039) | 2.92831817 |
| 54 | Pulmonary embolism (HP:0002204) | 2.91833955 |
| 55 | Gastrointestinal infarctions (HP:0005244) | 2.87979593 |
| 56 | Amyloidosis (HP:0011034) | 2.86723360 |
| 57 | Abnormality of T cells (HP:0002843) | 2.81166956 |
| 58 | Disinhibition (HP:0000734) | 2.79538958 |
| 59 | Epistaxis (HP:0000421) | 2.78159784 |
| 60 | Recurrent lower respiratory tract infections (HP:0002783) | 2.77616494 |
| 61 | Premature loss of primary teeth (HP:0006323) | 2.71919716 |
| 62 | Pulmonary infiltrates (HP:0002113) | 2.67515847 |
| 63 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.66519475 |
| 64 | Osteolytic defects of the hand bones (HP:0009699) | 2.66519475 |
| 65 | Vertebral compression fractures (HP:0002953) | 2.64973388 |
| 66 | Osteomyelitis (HP:0002754) | 2.64729854 |
| 67 | Poor head control (HP:0002421) | 2.64428045 |
| 68 | Gangrene (HP:0100758) | 2.62749416 |
| 69 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.60962858 |
| 70 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.60962858 |
| 71 | Abnormality of glycolipid metabolism (HP:0010969) | 2.60962858 |
| 72 | Nasal polyposis (HP:0100582) | 2.59238320 |
| 73 | Abnormality of the peritoneum (HP:0002585) | 2.58956926 |
| 74 | Autoimmune hemolytic anemia (HP:0001890) | 2.55554293 |
| 75 | Inflammation of the large intestine (HP:0002037) | 2.53830902 |
| 76 | Abnormality of the pleura (HP:0002103) | 2.48652127 |
| 77 | Microcytic anemia (HP:0001935) | 2.48340279 |
| 78 | Granulocytopenia (HP:0001913) | 2.46594638 |
| 79 | Glomerulonephritis (HP:0000099) | 2.41824298 |
| 80 | Myocardial infarction (HP:0001658) | 2.41551791 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.41365243 |
| 82 | Gingival bleeding (HP:0000225) | 2.41033964 |
| 83 | Sepsis (HP:0100806) | 2.39197613 |
| 84 | Hemoptysis (HP:0002105) | 2.37981776 |
| 85 | Meningitis (HP:0001287) | 2.37470587 |
| 86 | Abnormality of the nasal mucosa (HP:0000433) | 2.35627098 |
| 87 | Leukocytosis (HP:0001974) | 2.33604491 |
| 88 | Abnormality of the endocardium (HP:0004306) | 2.31528631 |
| 89 | Increased IgE level (HP:0003212) | 2.28386989 |
| 90 | Loss of speech (HP:0002371) | 2.28203548 |
| 91 | Acute hepatic failure (HP:0006554) | 2.27823981 |
| 92 | Bone pain (HP:0002653) | 2.25374784 |
| 93 | Prolonged neonatal jaundice (HP:0006579) | 2.24951763 |
| 94 | Progressive visual loss (HP:0000529) | 2.24053297 |
| 95 | Hepatosplenomegaly (HP:0001433) | 2.23788525 |
| 96 | Glomerulopathy (HP:0100820) | 2.23529433 |
| 97 | Subacute progressive viral hepatitis (HP:0006572) | 2.23341616 |
| 98 | Recurrent bronchitis (HP:0002837) | 2.20245517 |
| 99 | Panhypogammaglobulinemia (HP:0003139) | 2.19559470 |
| 100 | Nephritis (HP:0000123) | 2.19328414 |
| 101 | Peritonitis (HP:0002586) | 2.19220328 |
| 102 | Purpura (HP:0000979) | 2.18918680 |
| 103 | Petechiae (HP:0000967) | 2.18128815 |
| 104 | Keratitis (HP:0000491) | 2.16864844 |
| 105 | Vertigo (HP:0002321) | 2.14425675 |
| 106 | Eosinophilia (HP:0001880) | 2.13685029 |
| 107 | Hematochezia (HP:0002573) | 2.12136062 |
| 108 | Dysostosis multiplex (HP:0000943) | 2.11234916 |
| 109 | Abnormality of the pericardium (HP:0001697) | 2.11015432 |
| 110 | Viral hepatitis (HP:0006562) | 2.10841168 |
| 111 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.10795217 |
| 112 | Pathologic fracture (HP:0002756) | 2.10108817 |
| 113 | Arterial thrombosis (HP:0004420) | 2.08569267 |
| 114 | Skin ulcer (HP:0200042) | 2.07053431 |
| 115 | Cleft eyelid (HP:0000625) | 2.06733737 |
| 116 | Slow saccadic eye movements (HP:0000514) | 2.05295989 |
| 117 | Chronic sinusitis (HP:0011109) | 2.05199533 |
| 118 | Lymphopenia (HP:0001888) | 2.04653853 |
| 119 | Anorexia (HP:0002039) | 2.02815807 |
| 120 | Polycythemia (HP:0001901) | 2.01228699 |
| 121 | Acne (HP:0001061) | 1.99003953 |
| 122 | Thrombophlebitis (HP:0004418) | 1.98914714 |
| 123 | Emphysema (HP:0002097) | 1.98700415 |
| 124 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.97263740 |
| 125 | Abnormal platelet volume (HP:0011876) | 1.95131961 |
| 126 | Esophageal neoplasm (HP:0100751) | 1.94173806 |
| 127 | Neoplasm of head and neck (HP:0012288) | 1.94173806 |
| 128 | Abnormality of T cell number (HP:0011839) | 1.93078423 |
| 129 | Mucopolysacchariduria (HP:0008155) | 1.93029537 |
| 130 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93029537 |
| 131 | Arthralgia (HP:0002829) | 1.92645484 |
| 132 | Abnormality of T cell physiology (HP:0011840) | 1.92030777 |
| 133 | Colitis (HP:0002583) | 1.91064494 |
| 134 | Abnormality of the prostate (HP:0008775) | 1.90683924 |
| 135 | Joint swelling (HP:0001386) | 1.89278323 |
| 136 | Abnormality of the basal ganglia (HP:0002134) | 1.87982522 |
| 137 | Spontaneous hematomas (HP:0007420) | 1.87943495 |
| 138 | Polyneuropathy (HP:0001271) | 1.87499014 |
| 139 | Skin rash (HP:0000988) | 1.87220061 |
| 140 | Abnormality of eosinophils (HP:0001879) | 1.85376152 |
| 141 | Cheilitis (HP:0100825) | 1.85298488 |
| 142 | Agnosia (HP:0010524) | 1.84421334 |
| 143 | Amaurosis fugax (HP:0100576) | 1.82243465 |
| 144 | IgM deficiency (HP:0002850) | 1.81549545 |
| 145 | Toxemia of pregnancy (HP:0100603) | 1.79060112 |
| 146 | Difficulty running (HP:0009046) | 1.74599721 |
| 147 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.73202718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 5.37721912 |
| 2 | MAP3K14 | 4.81908447 |
| 3 | TYK2 | 3.90342606 |
| 4 | TBK1 | 3.76583532 |
| 5 | RIPK4 | 3.39436862 |
| 6 | IKBKE | 3.31009049 |
| 7 | MAP2K3 | 3.15476700 |
| 8 | BLK | 3.01956067 |
| 9 | IRAK4 | 2.96778820 |
| 10 | JAK3 | 2.88205267 |
| 11 | PIM2 | 2.69505955 |
| 12 | JAK1 | 2.67352297 |
| 13 | GRK6 | 2.33435073 |
| 14 | ERN1 | 2.28482694 |
| 15 | MAP3K13 | 2.28461484 |
| 16 | IKBKB | 2.22743834 |
| 17 | FGFR4 | 2.17562306 |
| 18 | IRAK3 | 2.14773379 |
| 19 | KIT | 2.06298122 |
| 20 | TNK2 | 1.97637400 |
| 21 | EPHA3 | 1.96595954 |
| 22 | EPHB1 | 1.78737945 |
| 23 | TXK | 1.71288159 |
| 24 | PRPF4B | 1.65499008 |
| 25 | TAOK3 | 1.57843860 |
| 26 | TAOK1 | 1.55144645 |
| 27 | CSK | 1.49500800 |
| 28 | MAP4K1 | 1.47761759 |
| 29 | CHUK | 1.45076321 |
| 30 | ARAF | 1.41389772 |
| 31 | MST4 | 1.41286937 |
| 32 | BMPR2 | 1.37255252 |
| 33 | FGFR3 | 1.36590294 |
| 34 | IRAK1 | 1.33104187 |
| 35 | MAP3K2 | 1.32599052 |
| 36 | MAP3K6 | 1.27621982 |
| 37 | EIF2AK2 | 1.27612659 |
| 38 | ABL2 | 1.23510366 |
| 39 | NEK9 | 1.23402621 |
| 40 | SYK | 1.20276504 |
| 41 | HCK | 1.15102117 |
| 42 | ITK | 1.13246463 |
| 43 | BMX | 1.12278826 |
| 44 | MAP3K5 | 1.11601649 |
| 45 | ZAP70 | 1.10243294 |
| 46 | CDK19 | 1.09004887 |
| 47 | MATK | 1.06793157 |
| 48 | JAK2 | 1.06301878 |
| 49 | NME2 | 1.01527152 |
| 50 | RPS6KA4 | 0.98591566 |
| 51 | STK4 | 0.97501497 |
| 52 | LYN | 0.97230988 |
| 53 | LCK | 0.96406899 |
| 54 | MARK2 | 0.92353159 |
| 55 | FGR | 0.91594478 |
| 56 | PIM1 | 0.89121710 |
| 57 | RIPK1 | 0.88787797 |
| 58 | MAP2K4 | 0.87370869 |
| 59 | PDK1 | 0.84778233 |
| 60 | PTK6 | 0.83817971 |
| 61 | PTK2B | 0.82923948 |
| 62 | MST1R | 0.80698698 |
| 63 | ERBB3 | 0.77591419 |
| 64 | CSF1R | 0.73493650 |
| 65 | PDPK1 | 0.70848513 |
| 66 | TRPM7 | 0.69981112 |
| 67 | KSR1 | 0.68999237 |
| 68 | IRAK2 | 0.67137356 |
| 69 | STK11 | 0.65408434 |
| 70 | EGFR | 0.64151589 |
| 71 | ABL1 | 0.62158013 |
| 72 | BTK | 0.62115529 |
| 73 | PRKD2 | 0.61036966 |
| 74 | PRKCD | 0.60477897 |
| 75 | NLK | 0.58791289 |
| 76 | SGK3 | 0.58398673 |
| 77 | FES | 0.57563452 |
| 78 | MAP2K6 | 0.56387186 |
| 79 | WNK1 | 0.55572089 |
| 80 | TAOK2 | 0.55551758 |
| 81 | MOS | 0.54567453 |
| 82 | RET | 0.54015888 |
| 83 | SIK2 | 0.53176558 |
| 84 | MAP3K7 | 0.52989714 |
| 85 | YES1 | 0.52929106 |
| 86 | DYRK3 | 0.52720161 |
| 87 | DAPK3 | 0.52244654 |
| 88 | TEC | 0.49393226 |
| 89 | MARK3 | 0.47991847 |
| 90 | SGK2 | 0.47982918 |
| 91 | CAMKK2 | 0.47522335 |
| 92 | MAPK12 | 0.46999434 |
| 93 | TRIB3 | 0.46660441 |
| 94 | STK38 | 0.46053076 |
| 95 | TESK2 | 0.45590793 |
| 96 | PRKCQ | 0.45576071 |
| 97 | MAP3K1 | 0.42758769 |
| 98 | HIPK2 | 0.40342864 |
| 99 | GRK7 | 0.39641866 |
| 100 | TGFBR2 | 0.38789030 |
| 101 | DAPK2 | 0.37967180 |
| 102 | STK10 | 0.37527251 |
| 103 | RPS6KA5 | 0.37178986 |
| 104 | MAPK7 | 0.37127809 |
| 105 | MAP3K10 | 0.36982504 |
| 106 | STK3 | 0.36042453 |
| 107 | DYRK1B | 0.35424732 |
| 108 | CAMKK1 | 0.34984826 |
| 109 | CLK1 | 0.33987552 |
| 110 | RPS6KL1 | 0.33455017 |
| 111 | RPS6KC1 | 0.33455017 |
| 112 | TESK1 | 0.32790990 |
| 113 | CDC42BPA | 0.31764437 |
| 114 | PRKCZ | 0.31349052 |
| 115 | SMG1 | 0.31060050 |
| 116 | SIK3 | 0.31037856 |
| 117 | ADRBK2 | 0.30856758 |
| 118 | PLK2 | 0.30818559 |
| 119 | ALK | 0.27591340 |
| 120 | PRKD1 | 0.26070376 |
| 121 | TTN | 0.25200965 |
| 122 | KSR2 | 0.23216092 |
| 123 | FYN | 0.23062478 |
| 124 | CDK6 | 0.22583055 |
| 125 | PKN1 | 0.22348657 |
| 126 | CAMK1D | 0.21097026 |
| 127 | BMPR1B | 0.20451879 |
| 128 | ERBB4 | 0.20368052 |
| 129 | INSR | 0.19833248 |
| 130 | MAPKAPK2 | 0.19676649 |
| 131 | DDR2 | 0.19133904 |
| 132 | IGF1R | 0.17974806 |
| 133 | LRRK2 | 0.17281062 |
| 134 | NUAK1 | 0.17166727 |
| 135 | MAP3K3 | 0.16258732 |
| 136 | RAF1 | 0.15781501 |
| 137 | MAP3K9 | 0.15212321 |
| 138 | SRC | 0.14287934 |
| 139 | RPS6KA1 | 0.12990409 |
| 140 | MAP3K11 | 0.12573744 |
| 141 | RPS6KA6 | 0.12132262 |
| 142 | PIK3CG | 0.11454835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.51129601 |
| 2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.34525873 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.17849400 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.17299699 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.08001927 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.82965068 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.74770117 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.61634427 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 2.42446681 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.39775508 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.38778170 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.32259648 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.29116635 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.27966435 |
| 15 | Influenza A_Homo sapiens_hsa05164 | 2.22986435 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.21760111 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.21550572 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.18897258 |
| 19 | Asthma_Homo sapiens_hsa05310 | 2.13948192 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.06558917 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 2.00318112 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.92710979 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.91059254 |
| 24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.89672749 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.68314870 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65088658 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.57193592 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.57136643 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56728374 |
| 30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.55460253 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.53519391 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48206803 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.47432593 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35596655 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.34289998 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.32512191 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.31841418 |
| 38 | Viral myocarditis_Homo sapiens_hsa05416 | 1.24151479 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.19934525 |
| 40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19482728 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.19083978 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.17939751 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10792096 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07765500 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.04811467 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99571413 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96013227 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93963503 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93948018 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.91626486 |
| 51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90116114 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 0.89305379 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83625988 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77751397 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73932599 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69959321 |
| 57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68137009 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66313823 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64802072 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64096894 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64044961 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62604816 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61854279 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60729246 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59710789 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59574573 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57789745 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55943305 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55054631 |
| 70 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54881951 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54216476 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52736160 |
| 73 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52700462 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52614103 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51230569 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51092352 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.50915743 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49368063 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48930306 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48233957 |
| 81 | Proteasome_Homo sapiens_hsa03050 | 0.47541358 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46690915 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46052428 |
| 84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45296247 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42439788 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42318565 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41994513 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.40867218 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40669550 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.40138145 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39830801 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39035553 |
| 93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38502107 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38474787 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37056643 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.34777994 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.32755091 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32677132 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30342697 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29655684 |
| 101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26845104 |
| 102 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.25803974 |
| 103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24960797 |
| 104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.22211199 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.21955253 |
| 106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.19670258 |
| 107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.17990838 |
| 108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.15158576 |
| 109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.13968518 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.11437141 |
| 111 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.11258004 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.11251100 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.11089403 |
| 114 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.10660543 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.08648982 |
| 116 | Prostate cancer_Homo sapiens_hsa05215 | 0.06423242 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.05950602 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.04499831 |

